Goldman Sachs’s Nobilis Health Corp. HLTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-13,091
| Closed | -$2K | – | 5524 |
|
|
2019
Q2 | $2K | Buy |
+13,091
| New | +$2.55K | ﹤0.01% | 5094 |
|
|
2018
Q4 | – | Sell |
-209,708
| Closed | -$210K | – | 5893 |
|
|
2018
Q3 | $210K | Buy |
209,708
+182,117
| +660% | +$179K | ﹤0.01% | 4900 |
|
|
2018
Q2 | $33K | Sell |
27,591
-311
| -1% | -$431 | ﹤0.01% | 5438 |
|
|
2018
Q1 | $46K | Buy |
27,902
+125
| +0.5% | +$182 | ﹤0.01% | 5496 |
|
|
2017
Q4 | $37K | Sell |
27,777
-112
| -0.4% | -$155 | ﹤0.01% | 6004 |
|
|
2017
Q3 | $42K | Sell |
27,889
-666,982
| -96% | -$1.05M | ﹤0.01% | 6295 |
|
|
2017
Q2 | $1.32M | Buy |
694,871
+557,230
| +405% | +$843K | ﹤0.01% | 4203 |
|
|
2017
Q1 | $234K | Buy |
137,641
+76,154
| +124% | +$158K | ﹤0.01% | 5635 |
|
|
2016
Q4 | $129K | Buy |
61,487
+13,407
| +28% | +$36.5K | ﹤0.01% | 6017 |
|
|
2016
Q3 | $161K | Sell |
48,080
-18,231
| -27% | -$54.8K | ﹤0.01% | 5963 |
|
|
2016
Q2 | $148K | Buy |
66,311
+9,417
| +17% | +$30.5K | ﹤0.01% | 5904 |
|
|
2016
Q1 | $178K | Buy |
56,894
+34,288
| +152% | +$88.7K | ﹤0.01% | 5710 |
|
|
2015
Q4 | $63K | Sell |
22,606
-8,464
| -27% | -$27.1K | ﹤0.01% | 6427 |
|
|
2015
Q3 | $162K | Buy |
+31,070
| New | +$178K | ﹤0.01% | 6151 |
|
Other funds holding HLTH
Goldman Sachs's HLTH Position: Q3 2019 in Review
Goldman Sachs sold out of Nobilis Health Corp. (HLTH) in Q3 2019, closing a stake of 13,091 shares — an estimated $2K sold.
Goldman Sachs first reported a position in HLTH in Q3 2015 and held it in 14 quarters. The position peaked at $1.32M in Q2 2017. 3 funds tracked by Wall St. Rank hold HLTH as of Q3 2019.
- Goldman Sachs reported no remaining Nobilis Health Corp. position as of Q3 2019 after selling out during the quarter.
- Goldman Sachs sold 13,091 Nobilis Health Corp. shares in Q3 2019, an estimated $2K.
- Goldman Sachs first reported a position in Nobilis Health Corp. in Q3 2015 and held it in 14 quarters.
- Goldman Sachs's Nobilis Health Corp. position peaked at $1.32M in Q2 2017.
- 3 funds tracked by Wall St. Rank held Nobilis Health Corp. as of Q3 2019.
Based on Goldman Sachs's 13F filing for Q3 2019, filed 14 Nov 2019.